Skip to Content

Join the 'Prostate Cancer' group to help and get support from people like you.

Prostate Cancer News

Related terms: Cancer, Prostate, Carcinoma of Prostate

Could a Common Blood Thinner Lower Cancer Risk?

Posted 18 days ago by Drugs.com

MONDAY, Nov. 6, 2017 – A pill widely taken to prevent heart attack and stroke may also guard against cancer, new research suggests. Warfarin is an inexpensive blood thinner. It's typically prescribed for patients whose leg arteries are prone to clots and for patients with the abnormal heartbeat called atrial fibrillation. Now, Norwegian investigators say it may also protect against any type of cancer and from prostate, lung and breast cancer, in particular. Lower colon cancer risk was also reported, but only in people taking warfarin for A-fib, according to the study. The findings don't prove that warfarin reduces the risk of cancer, cautioned lead researcher James Lorens. "This is an observational study using data on more than 1.25 million people 50 and older from Norwegian national registries, and cannot prove a cause-and-effect relationship," said Lorens, a professor of biomedicine ... Read more

Related support groups: Cancer, Warfarin, Atrial Fibrillation, Coumadin, Breast Cancer, Heart Attack, Prostate Cancer, Lung Cancer, Myocardial Infarction, Jantoven, Myocardial Infarction - Prophylaxis

Speed Up the 'Cancer Moonshot,' Doctors Urge

Posted 1 Nov 2017 by Drugs.com

TUESDAY, Oct. 31, 2017 – The Cancer Moonshot Initiative now has a detailed road map designed to cram a decade's worth of medical advancement into half that time. A new report, authored by more than 50 leading U.S. cancer doctors, highlights 13 priority areas for improving the medical response to cancer, along with measurable goals and a specific timeline for meeting each of those objectives. The plan is intended to help "accelerate existing progress so that we deliver in five years what would have historically taken 10," said Dr. Cliff Hudis, chief executive officer of the American Society of Clinical Oncology and co-author of the report. It was created by The Lancet Oncology Commission on Future Research Priorities in the USA. In late 2016, Congress appropriated $1.8 billion for cancer research funding over the next seven years for the so-called Cancer Moonshot, said commission ... Read more

Related support groups: Cancer, Methotrexate, Breast Cancer, Prostate Cancer, Fluorouracil, Gleevec, Lung Cancer, Colorectal Cancer, Non-Small Cell Lung Cancer, Melanoma, Xeloda, Tasigna, Sprycel, Hydroxyurea, Herceptin, Cervical Cancer, Mercaptopurine, Hydrea, Cisplatin, Carboplatin

Health Tip: Recognizing Prostate Cancer

Posted 29 Sep 2017 by Drugs.com

-- Prostate cancer is the most common form of cancer among men. And black men are more likely to get the disease, and twice as likely to die from it, the U.S. Food and Drug Administration says. The slow-growing disease often shows few or no symptoms until it's too late. But if symptoms do emerge, they may include: Difficulty beginning urination. Weak or interrupted flow of urine. Frequent urination, especially at night. Since these symptoms also may be related to other causes, such as an enlarged prostate, men who have these symptoms should see a doctor without delay, the FDA says. Read more

Related support groups: Benign Prostatic Hyperplasia (BPH), Overactive Bladder, Prostate Cancer, Urinary Incontinence, Prostatitis, Prostate Tumor - Benign

Fewer Uninsured Cancer Patients After Medicaid Expansion

Posted 27 Sep 2017 by Drugs.com

WEDNESDAY, Sept. 27, 2017 – States that expanded Medicaid under the Affordable Care Act halved the number of uninsured cancer patients, a new U.S. study finds. This matters because "uninsured cancer patients are more likely to go without needed care and treatment, such as radiation therapy or surgery to remove tumors," said study lead author Dr. Fumiko Chino. She is a radiation oncology resident at the Duke University School of Medicine. Chino and her colleagues analyzed the records of more than 197,000 cancer patients ages 18 to 64. All were newly diagnosed with cancer between 2011 and 2014 and received radiation as part of their treatment. The percentage of uninsured patients fell 52 percent on average in states that expanded Medicaid, while Medicaid enrollment rose from 15 to 18 percent. Medicaid is the publicly funded insurance program for the poor. In states that did not expand ... Read more

Related support groups: Breast Cancer, Prostate Cancer, Lung Cancer, Colorectal Cancer, Non-Small Cell Lung Cancer, Brain Tumor, Skin Cancer, Cervical Cancer, Testicular Cancer, Solid Tumors

Where It's Legal, One-Quarter of Cancer Patients Use Medical Pot

Posted 25 Sep 2017 by Drugs.com

MONDAY, Sept. 25, 2017 – If you legalize medical marijuana, a sizable number of cancer patients will sign up, a new Washington state survey suggests. One-quarter of cancer patients in Washington use marijuana, researchers found. But the study also revealed it can be a challenge to get information about the drug from health care providers. "Cancer patients desire but are not receiving information from their cancer doctors about marijuana use during their treatment, so many of them are seeking information from alternate nonscientific sources," said study author Dr. Steven Pergam of Fred Hutchinson Cancer Research Center in Seattle. Marijuana is reported to ease symptoms related to cancer treatment, and U.S. cancer patients will have greater access to medical pot as acceptance and availability of marijuana increases nationwide, Pergam's team said. Currently, recreational marijuana is ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Lung Cancer, Colorectal Cancer, Cannabis, Cervical Cancer

Prostate Cancer Symptoms Aren't Always Obvious

Posted 20 Sep 2017 by Drugs.com

WEDNESDAY, Sept. 20, 2017 – Although about 1 in 7 men will be eventually be diagnosed with prostate cancer in his lifetime, the warning signs of the disease are often vague and may be confused with other conditions, experts at Fox Chase Cancer Center say. Prostate cancer can be serious but it's often not fatal. Men should talk to their doctor about the risks and benefits of getting screened for the disease, advised Dr. Alexander Kutikov, chief of the division of urologic oncology at Fox Chase in Philadelphia. "Considering how often prostate cancer occurs in men, every man should familiarize himself with its signs and risk factors," Kutikov said in a center news release. "Yet, not all men should be screened for prostate cancer. Ultimately, the decision to get screened needs to be weighed in terms of the advantages and disadvantages of screening. Men should familiarize themselves with ... Read more

Related support groups: Benign Prostatic Hyperplasia (BPH), Prostate Cancer, Prostatitis, Diagnosis and Investigation, Prostate Tumor - Benign

Many May Get Hospice Care Too Late

Posted 12 Sep 2017 by Drugs.com

TUESDAY, Sept. 12, 2017 – Despite a growing list of debilitating symptoms during the final months of life, most seniors never receive end-of-life hospice care – or they delay doing so until their last few weeks of life, new research finds. "The main message is that the duration of hospice is very short," explained lead study author Dr. Thomas Gill. This, despite the fact that his team "documented high rates of distressing symptoms well before the start of hospice." Gill is the director of the Yale University Program on Aging. "Since hospice is designed to help alleviate distressing symptoms – including pain, nausea and anxiety, among others – our findings suggest that health care providers might need to consider discussing referrals to hospice sooner with older persons who are approaching the end of their lives," Gill added. The National Hospice and Palliative Care Organization ... Read more

Related support groups: Cancer, Breast Cancer, Dementia, Prostate Cancer, Alzheimer's Disease, Lung Cancer, Colorectal Cancer, Mild Cognitive Impairment, Solid Tumors, Lewy Body Dementia

'Cancer Pen' Could Help Surgeons Spot Tumor Cells in Seconds

Posted 6 Sep 2017 by Drugs.com

WEDNESDAY, Sept. 6, 2017 – A new "cancer pen" promises to help surgeons immediately detect and completely remove cancerous tumor tissue, without having to send samples off to a lab for testing while the patient languishes on the table. The MasSpec Pen is a hand-held device that allows doctors to test in real-time whether tissue is cancerous or not, delivering results in about 10 seconds, researchers report. The pen will make it easier to surgically clear out all the cancer cells surrounding a tumor, explained senior researcher Livia Eberlin, an assistant professor of chemistry with the University of Texas at Austin. In particular, cancers such as those of the breast, pancreas and brain "tend to invade surrounding normal tissue," Eberlin said. "For a surgeon, it can be really tricky, because these cells resemble normal tissue. Just judging by [the] eye, it can be very challenging." The ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Brain Tumor, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Diagnosis and Investigation

New Research Finds Value in PSA Testing

Posted 5 Sep 2017 by Drugs.com

TUESDAY, Sept. 5, 2017 – Despite ongoing debate over the value of prostate cancer screening, a new review says it can indeed reduce a man's risk of dying from the disease. Early tumor detection using the prostate-specific antigen (PSA) blood test lowers a man's risk of prostate cancer death by 25 percent to 32 percent, the new analysis of two major trials of PSA testing found. "The amount of early diagnosis was very strongly correlated with the reduced risk of prostate cancer death," said senior researcher Ruth Etzioni, a biostatistician with the Fred Hutchinson Cancer Research Center in Seattle. However, there's still a good chance that many men will wind up treated for prostate cancer that would not have killed them, Etzioni said. "There are definitely harms and, on average, in a population probably five times as many men will be overtreated as will be saved," Etzioni said. Because ... Read more

Related support groups: Prostate Cancer, Diagnosis and Investigation

Common Treatment for Early Prostate Cancer May Carry Heart Risk

Posted 25 Aug 2017 by Drugs.com

FRIDAY, Aug. 25, 2017 – Because testosterone can help prostate tumors grow, men with prostate cancer are often given hormone-suppressing treatment. But new research suggests that delivering the treatment in prostate cancer's early stages may, in turn, hike a man's odds for another illness – heart failure. The treatment in question is known as androgen-deprivation therapy. The take-home message from the new study is that "patients with localized prostate cancer should be followed to minimize the health effects of androgen-deprivation therapy on the cardiovascular system," said study author Reina Haque. She's a researcher with the Kaiser Permanente Southern California Department of Research & Evaluation. Haque's advice? "Patients should consider [heart-healthy] lifestyle changes, and physicians should actively monitor the patient's health for early signs of heart disease," she said in a ... Read more

Related support groups: Testosterone, Prostate Cancer, AndroGel, Testim, Axiron, Androderm, Casodex, Fortesta, Xtandi, Depo-Testosterone, Testopel, Bicalutamide, Testopel Pellets, Testim 5 g/packet, Flutamide, AndroGel 1.25 g/actuation, Nilutamide, Everone, Delatestryl, Testosterone Topical

Cancer Takes Financial Toll, Even With Insurance

Posted 10 Aug 2017 by Drugs.com

THURSDAY, Aug. 10, 2017 – Many cancer patients in the United States are shocked by their out-of-pocket costs for care – with some spending one-third of their income on treatment, a new study finds. The study looked at the financial toll of cancer treatment on people who have health insurance. The vast majority in the study had private insurance or Medicare coverage; the rest were on Medicaid, the government insurance program for poor Americans. Despite that, the study found, patients typically spent nearly $600 a month on their treatment. Overall, 16 percent said they were facing "high or overwhelming financial distress." Those patients were spending nearly one-third of their monthly income on cancer care. Dr. Yousuf Zafar, the senior researcher on the study, used the term "financial toxicity." "Oncologists talk about the toxicities of cancer treatment. But there can also be a ... Read more

Related support groups: Anxiety and Stress, Cancer, Breast Cancer, Prostate Cancer, Lung Cancer, Colorectal Cancer, Non-Small Cell Lung Cancer, Skin Cancer, Small Cell Lung Cancer, Melanoma - Metastatic, Stomach Cancer, Head and Neck Cancer, Gastric Cancer, Testicular Cancer, Choriocarcinoma

Treatment Costs Can Be Another Blow to Cancer Patients

Posted 27 Jul 2017 by Drugs.com

THURSDAY, July 27, 2017 – The emotional and physical costs of cancer can be staggering. But the financial side of cancer is also a great burden, with many patients in the United States struggling to pay for treatment, new research reveals. "The current health law has greatly improved access to meaningful health coverage for cancer patients, survivors and all those with chronic diseases," Chris Hansen, president of the American Cancer Society Cancer Action Network, said in a network news release. "Yet costs remain a challenge for those facing cancer. Our country and our lawmakers should come together to find bipartisan solutions that begin to address patient costs without sacrificing the quality of coverage," he urged. Researchers surveyed financial navigators at 11 hospitals in nine states. Financial navigators – typically trained social workers or nurses – help cancer patients ... Read more

Related support groups: Cancer, Depo-Provera, Provera, Breast Cancer, Lupron, Prostate Cancer, Medroxyprogesterone, Tamoxifen, Arimidex, Lupron Depot, Femara, Gleevec, Lung Cancer, Colorectal Cancer, Non-Small Cell Lung Cancer, Anastrozole, Brain Tumor, Letrozole, Skin Cancer, Tarceva

Insured, But Still Barred From Top-Tier Cancer Centers

Posted 20 Jul 2017 by Drugs.com

THURSDAY, July 20, 2017 – Choosing a cheaper health plan could cost you access to cream-of-the-crop cancer doctors and facilities, a new study reports. Less-expensive "narrow network" health plans are much less likely to cover treatment by doctors at centers affiliated with the U.S. National Cancer Institute, said study lead author Laura Yasaitis. "We found that the narrower networks were more likely to systematically exclude NCI-affiliated physicians," said Yasaitis, a postdoctoral researcher with the University of Pennsylvania School of Medicine. "The oncologists they included in their networks were about half as likely to be NCI-affiliated as those they excluded." NCI-Designated Cancer Centers are the nation's top-flight facilities for cancer care, and studies have shown that patients treated at these centers tend to have better outcomes, Yasaitis said. Access to these centers is ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Lung Cancer, Colorectal Cancer, Non-Small Cell Lung Cancer, Brain Tumor, Cervical Cancer, Breast Cancer, Prevention, Head and Neck Cancer, Gastric Cancer

More Patients OK'd for Cancer Trials Under Obamacare: Study

Posted 20 Jul 2017 by Drugs.com

THURSDAY, July 20, 2017 – The Affordable Care Act has enabled more privately insured patients to enroll in clinical trials for new cancer treatments, a new study contends. Speedy approvals are important for patients who want to participate in clinical trials, said study author Dr. David Hong. He's deputy chair of investigational cancer therapeutics at the University of Texas MD Anderson Cancer Center. Since 2000, Medicare, the publicly funded insurance program for seniors, has covered routine costs of clinical trial participation. But coverage for patients with private insurance differed by insurer and state, the researchers noted. Under the ACA, or Obamacare, however, private insurers had to cover "standard of care" costs of clinical trial participation as of 2014. For this study, the researchers analyzed more than 2,400 patient referrals to the Clinical Center for Targeted Therapy at ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Gleevec, Lung Cancer, Colorectal Cancer, Non-Small Cell Lung Cancer, Votrient, Tarceva, Tasigna, Avastin, Pancreatic Cancer, Sprycel, Sutent, Afinitor, Nexavar, Cisplatin, Carboplatin, Cytoxan, Bendamustine

Many Terminal Cancer Patients Remain in Denial

Posted 20 Jul 2017 by Drugs.com

WEDNESDAY, July 19, 2017 – Nearly 10 percent of patients with terminal cancer don't want to know they're dying, which can make their final days more difficult, a new study finds. Unwillingness to face poor prospects can lead to unnecessary treatments and keep patients from making end-of-life plans, the researchers reported recently in The Oncologist. "Health care professionals should appropriately assess patients' readiness for prognostic information," said study leader Siew-Tzuh Tang, a professor at Chang Gung University School of Nursing in Taiwan. Doctors should respect patients' reluctance to confront their poor prognosis if they are not ready to know, "but sensitively coach them to cultivate their accurate prognostic awareness," Tang said in a journal news release. The study involved nearly 250 terminal cancer patients in Taiwan. They were questioned several times over their last ... Read more

Related support groups: Anxiety, Generalized Anxiety Disorder, Anxiety and Stress, Cancer, Post Traumatic Stress Disorder, Social Anxiety Disorder, Breast Cancer, Prostate Cancer, Lung Cancer, Renal Cell Carcinoma, Colorectal Cancer, Non-Small Cell Lung Cancer, Brain Tumor, Breast Cancer, Metastatic, Skin Cancer, Ovarian Cancer, Pancreatic Cancer, Cervical Cancer, Breast Cancer, Prevention, Stomach Cancer

Page 1 2 3 ... Next

Ask a Question

Further Information

Related Condition Support Groups

Cancer

Related Drug Support Groups

estradiol, Premarin, Estrace, ethinyl estradiol, Lupron Depot, Zoladex, Zytiga, Estradiol Patch, Casodex, view more... Taxotere, Eligard, Cenestin, Xtandi, capecitabine, bicalutamide, cyclophosphamide, flax, Enjuvia, esterified estrogens, Menest, Xofigo, degarelix, Trelstar, conjugated estrogens, Trelstar LA, goserelin, Vantas, Provenge, Firmagon, leuprolide, radium 223 dichloride, docetaxel, Progynova, flutamide, Flax Seed Oil, Sandrena, Jevtana, Thais, Supprelin LA, Premarin Intravenous, Zoladex 3-Month, Trelstar Depot, nilutamide, sipuleucel-t, Delestrogen, abiraterone, Thaissept, diethylstilbestrol, estramustine, Docefrez, histrelin, mitoxantrone, triptorelin, Estratab, cabazitaxel, enzalutamide, Stilphostrol, Systen, Plenaxis, Viadur, Provames, Oromone, Primogyn Depot, Cytadren, Zumenon, Progynova TS, Emcyt, Valergen, Eulexin, Estinyl, aminoglutethimide, Novantrone, Nilandron, abarelix